4.7 Article

Impact of Ivermectin on the Gut Microbial Ecosystem

Related references

Note: Only part of the references are listed.
Review Immunology

A cellular and molecular biology-based update for ivermectin against COVID-19: is it effective or non-effective?

Mohsen Nabi-Afjadi et al.

Summary: Despite challenges in treatment options for COVID-19, including new virus variants and diversified use of antiviral drugs, ivermectin has potential as a treatment but its efficacy and safety in treating SARS-CoV-2 are still controversial.

INFLAMMOPHARMACOLOGY (2023)

Article Nutrition & Dietetics

Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota

William Fusco et al.

Summary: Short-chain fatty acids (SCFAs) are crucial for gut health and have implications in various diseases. They are produced by specific bacterial taxa in the gut microbiota and can be influenced by specific foods or supplements. This review provides an overview of SCFAs, their production by bacteria, and potential therapeutic approaches to boost their levels and treat related diseases.

NUTRIENTS (2023)

Review Food Science & Technology

The Interplay of Dietary Fibers and Intestinal Microbiota Affects Type 2 Diabetes by Generating Short-Chain Fatty Acids

Muhammad Mazhar et al.

Summary: Foods contain dietary fibers which can be classified into soluble and insoluble forms. The nutritional composition of fast foods is considered unhealthy because it negatively affects the production of short-chain fatty acids (SCFAs). SCFAs, produced by the anaerobic intestinal microbiota (AIM) through the fermentation of dietary fiber, have beneficial effects on type 2 diabetes (T2D) by enhancing insulin sensitivity or secretion, beta-cell function, and intestinal gluconeogenesis, and promoting the release of hormones like PYY, GLP-1, and leptin. This review focuses on the effectiveness of dietary fiber in producing SCFAs in the colon by the AIM, and its health-promoting effects on T2D.

FOODS (2023)

Article Chemistry, Medicinal

Exploring the Association between Citrus Nutraceutical Eriocitrin and Metformin for Improving Pre-Diabetes in a Dynamic Microbiome Model

Thais Cesar et al.

Summary: Pre-diabetes is an altered metabolic state associated with dysbiosis of the intestinal microbiota. Eriomin((R)), a natural compound, has been studied as an alternative or adjunct to conventional hypoglycemic agents. In this study, Eriomin((R)) plus metformin improved the composition and metabolism of the intestinal microbiota in pre-diabetic patients.

PHARMACEUTICALS (2023)

Article Multidisciplinary Sciences

Fiber supplementation protects from antibiotic-induced gut microbiome dysbiosis by modulating gut redox potential

Swathi Penumutchu et al.

Summary: This study explores dietary fiber supplements as potential modulators to reduce gut dysbiosis caused by antibiotics. The results suggest that fiber prebiotics significantly reduce the impact of antibiotic treatment on the microbiome composition and function, leading to a decrease in the abundance of anaerobic bacteria and metabolic pathways associated with oxidative metabolism.

NATURE COMMUNICATIONS (2023)

Review Biotechnology & Applied Microbiology

Production of short-chain fatty acids (SCFAs) as chemicals or substrates for microbes to obtain biochemicals

Elia Tomas-Pejo et al.

Summary: Carboxylic acids have become versatile platform molecules due to their ability to act as carbon sources for microorganisms and precursors for the chemical industry. Short-chain fatty acids (SCFAs) such as acetic, propionic, butyric, valeric, and caproic acids can be produced through anaerobic fermentation from various organic wastes. This review article provides an overview of SCFAs biosynthesis from waste products and explores their applications as bioproducts for a circular economy. Microbial conversion of SCFAs into biopolymers and other bioproducts is discussed with recent examples, highlighting the potential of SCFAs as platform molecules for future bioeconomy development.

BIOTECHNOLOGY FOR BIOFUELS AND BIOPRODUCTS (2023)

Review Biotechnology & Applied Microbiology

The mechanisms of action of ivermectin against SARS-CoV-2-an extensive review

Asiya Kamber Zaidi et al.

Summary: This review article discusses the possible mechanisms of action of ivermectin against SARS-CoV-2 by summarizing the available literature over the years. It proposes a schematic of the key cellular and biomolecular interactions between ivermectin, host cell, and SARS-CoV-2 in COVID-19 pathogenesis and prevention of complications.

JOURNAL OF ANTIBIOTICS (2022)

Editorial Material Infectious Diseases

Ivermectin for mass drug administration against malaria

Pauline Byakika-Kibwika et al.

LANCET INFECTIOUS DISEASES (2022)

Review Multidisciplinary Sciences

Prevalence and antimicrobial resistance pattern of Clostridium difficile among hospitalized diarrheal patients: A systematic review and meta-analysis

Tebelay Dilnessa et al.

Summary: A high prevalence of C. difficile was observed among hospitalized patients, emphasizing the need for attention and prevention. The resistance of C. difficile to metronidazole and vancomycin was lower compared to other antibiotics.

PLOS ONE (2022)

Review Immunology

Ivermectin for the Treatment of Coronavirus Disease 2019: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Yuani M. Roman et al.

Summary: This systematic review found that in patients with mostly mild COVID-19, ivermectin did not reduce all-cause mortality, hospital stays, or viral clearance compared to the control group. Therefore, ivermectin is not a viable treatment option for COVID-19.

CLINICAL INFECTIOUS DISEASES (2022)

Article Multidisciplinary Sciences

Different gut microbial communities correlate with efficacy of albendazole-ivermectin against soil-transmitted helminthiases

Pierre H. H. Schneeberger et al.

Summary: This study analyzed the microbiome of Trichuris trichiura and hookworm-infected patients and found an association between different enterotypes and treatment efficacy. The pre-treatment enterotype was found to predict the treatment outcome of combination therapy for both T. trichiura and hookworm infections.

NATURE COMMUNICATIONS (2022)

Article Nutrition & Dietetics

Analysis of the Ability of Capsaicin to Modulate the Human Gut Microbiota In Vitro

Karley K. Mahalak et al.

Summary: In this study, we found that regular consumption of capsaicin can change the structure of the gut microbial community and increase the abundance of certain short-chain fatty acids, particularly butanoic acid. These changes may be responsible for the health benefits associated with capsaicin consumption.

NUTRIENTS (2022)

Article Biotechnology & Applied Microbiology

Could the COVID-19-Driven Increased Use of Ivermectin Lead to Incidents of Imbalanced Gut Microbiota and Dysbiosis?

Leon M. T. Dicks et al.

Summary: This review investigates the antimicrobial properties of ivermectin, its possible mode of activity, and the concern that using the drug to treat COVID-19 may lead to dysbiosis.

PROBIOTICS AND ANTIMICROBIAL PROTEINS (2022)

Article Biochemistry & Molecular Biology

Persistence of the Probiotic Lacticaseibacillus rhamnosus Strain GG (LGG) in an In Vitro Model of the Gut Microbiome

Karley K. Mahalak et al.

Summary: This study investigated the interaction between LGG and the gut microbiome using an in vitro colon model. The results showed that LGG could survive and grow in the gut, and had some impact on the bacterial communities.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Biochemistry & Molecular Biology

Helminths and Bacterial Microbiota: The Interactions of Two of Humans' Old Friends

Kevin Llinas-Caballero et al.

Summary: Helminths and bacterial microbiota can interact with each other, and specific bacterial taxa can contribute to the susceptibility to certain helminths. The high diversity of gut microbiota is associated with the high burden of helminth infections, and helminth infections are associated with the risk of certain diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Medicine, Research & Experimental

Repurposing the drug, ivermectin, in COVID-19: toxicological points of view

Farshad M. Shirazi et al.

Summary: The global COVID-19 pandemic has led to changes in behavior and the evaluation of potential therapies, including ivermectin. While ivermectin appears to be safe with minimum side effects, there are still serious questions about its effectiveness in treating patients with COVID-19.

EUROPEAN JOURNAL OF MEDICAL RESEARCH (2022)

Article Veterinary Sciences

Ivermectin (IVM) Possible Side Activities and Implications in Antimicrobial Resistance and Animal Welfare: The Authors' Perspective

Cristian Piras et al.

Summary: Ivermectin has diverse functions and is particularly important in treating parasitic diseases in both human and veterinary medicine. It also has antibacterial, antiviral, and anti-inflammatory properties. Research is ongoing to understand its impact as an antimicrobial and immunomodulator.

VETERINARY SCIENCES (2022)

Review Pharmacology & Pharmacy

Ivermectin, a potential anticancer drug derived from an antiparasitic drug

Mingyang Tang et al.

Summary: Ivermectin is a macrolide antiparasitic drug widely used in treating parasitic diseases, and recent studies show its potential as an anticancer drug by inhibiting tumor cell proliferation through multiple signaling pathways. This indicates a promising prospect for the clinical application of ivermectin in cancer therapy.

PHARMACOLOGICAL RESEARCH (2021)

Review Parasitology

Ivermectin: An Anthelmintic, an Insecticide, and Much More

Richard J. Martin et al.

Summary: Ivermectin has diverse effects, including anthelmintic and insecticidal actions as well as antiviral, antimalarial, antimetabolic, and anticancer effects. However, caution is needed when considering its repositioning for the treatment of other diseases, particularly Covid-19, due to the potential risks associated with the high concentrations used in tissue-culture experiments.

TRENDS IN PARASITOLOGY (2021)

Review Endocrinology & Metabolism

Micronutrients impact the gut microbiota and blood glucose

Nicole G. Barra et al.

Summary: Micronutrients play a crucial role in influencing host metabolism and hormone action. They have the ability to alter host-microbe symbiosis, which in turn affects endocrine control of glucose metabolism and is associated with metabolic disease risk and progression. Further research is needed to fully understand the causal effects of micronutrients on host-microbe metabolism and the mechanisms linking dietary micronutrient status to changes in gut microbes linked to metabolic diseases.

JOURNAL OF ENDOCRINOLOGY (2021)

Review Biochemistry & Molecular Biology

Helminth extracellular vesicles: Interactions with the host immune system

Claire Drurey et al.

Summary: As long-lived parasites, helminths manipulate their hosts' immune system by secreting extracellular vesicles (EVs) containing immune modulators, which could be targeted for treatment of helminth infections.

MOLECULAR IMMUNOLOGY (2021)

Article Gastroenterology & Hepatology

Distal colonic transit is linked to gut microbiota diversity and microbial fermentation in humans with slow colonic transit

Mattea Muller et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2020)

Review Microbiology

Harnessing the gut microbiome in the fight against anthelminthic drug resistance

Thomas J. Sharpton et al.

CURRENT OPINION IN MICROBIOLOGY (2020)

Letter Biotechnology & Applied Microbiology

PICRUSt2 for prediction of metagenome functions

Gavin M. Douglas et al.

NATURE BIOTECHNOLOGY (2020)

Article Biotechnology & Applied Microbiology

The impact of anthelmintic treatment on gut bacterial and fungal communities in diagnosed parasite-free sika deer Cervus nippon

Xiaolong Hu et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)

Article Multidisciplinary Sciences

Triclosan has a robust, yet reversible impact on human gut microbial compositionin vitro

Karley K. Mahalak et al.

PLOS ONE (2020)

Article Biotechnology & Applied Microbiology

Short-chain fatty acids production by Bifidobacterium species in the presence of salep

Buse Usta-Gorgun et al.

ELECTRONIC JOURNAL OF BIOTECHNOLOGY (2020)

Article Cell Biology

Ivermectin inhibits extracellular vesicle secretion from parasitic nematodes

Hannah J. Loghry et al.

JOURNAL OF EXTRACELLULAR VESICLES (2020)

Review Microbiology

Drug Repurposing for the Treatment of Bacterial and Fungal Infections

Andrea Miro-Canturri et al.

FRONTIERS IN MICROBIOLOGY (2019)

Letter Biotechnology & Applied Microbiology

Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2

Evan Bolyen et al.

NATURE BIOTECHNOLOGY (2019)

Review Microbiology

Regional Diversity of the Gastrointestinal Microbiome

Kristina Martinez-Guryn et al.

CELL HOST & MICROBE (2019)

Article Multidisciplinary Sciences

Establishing a mucosal gut microbial community in vitro using an artificial simulator

LinShu Liu et al.

PLOS ONE (2018)

Article Parasitology

Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota

Pierre H. H. Schneeberger et al.

INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2018)

Article Public, Environmental & Occupational Health

In vitro activity of ivermectin against Staphylococcus aureus clinical isolates

Shoaib Ashraf et al.

ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2018)

Review Microbiology

Formation of propionate and butyrate by the human colonic microbiota

Petra Louis et al.

ENVIRONMENTAL MICROBIOLOGY (2017)

Article Biochemical Research Methods

DADA2: High-resolution sample inference from Illumina amplicon data

Benjamin J. Callahan et al.

NATURE METHODS (2016)

Review Dermatology

New developments in the treatment of rosacea - role of once-daily ivermectin cream

Leah A. Cardwell et al.

CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2016)

Review Biochemical Research Methods

TEER Measurement Techniques for In Vitro Barrier Model Systems

Balaji Srinivasan et al.

Article Biochemistry & Molecular Biology

MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability

Kazutaka Katoh et al.

MOLECULAR BIOLOGY AND EVOLUTION (2013)

Article Biochemistry & Molecular Biology

The SILVA ribosomal RNA gene database project: improved data processing and web-based tools

Christian Quast et al.

NUCLEIC ACIDS RESEARCH (2013)

Article Biotechnology & Applied Microbiology

Incorporating a mucosal environment in a dynamic gut model results in a more representative colonization by lactobacilli

Pieter Van den Abbeele et al.

MICROBIAL BIOTECHNOLOGY (2012)

Review Multidisciplinary Sciences

Ivermectin, 'Wonder drug' from Japan: the human use perspective

Andy Crump et al.

PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2011)

Article Biotechnology & Applied Microbiology

Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities

Catherine A. Lozupone et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)

Article Biotechnology & Applied Microbiology

UniFrac: a new phylogenetic method for comparing microbial communities

C Lozupone et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2005)

Article Pharmacology & Pharmacy

Intestinal secretion is a major route for parent ivermectin elimination in the rat

C Laffont et al.

DRUG METABOLISM AND DISPOSITION (2002)

Article Parasitology

Ivermectin: effectiveness in lymphatic filariasis

KR Brown et al.

PARASITOLOGY (2000)